Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rank in Stocks #6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Share Price
$14.30
Last synced: 2023-06-29
Market Cap
$1.81B
Change (1 day)
-2.81%
Change (1 year)
0.00%
Country
CA
Trade BELLUS Health Inc. (BLU)

Category

Stock price history for BELLUS Health Inc. (BLU)
Highest end of day price: $14.62 on 2023-06-01

Lowest end of day price: $617.12 on 2000-06-01
Stock price history of BELLUS Health Inc. from 2000 to 2026
Annual Stock Price Performance
Year Performance
2023 56.80%
2022 31.13%
2021 132.06%
2020 -56.49%
2019 141.94%
2018 161.76%
2017 54.42%
2016 -72.16%
2015 -39.98%
2014 212.05%
2013 -6.93%
2012 -69.52%
2011 -61.15%
2010 -32.03%
2009 -57.70%
2008 -83.40%
2007 -89.98%
2006 82.43%
2005 -27.25%
2004 -7.64%
2003 313.71%
2002 87.44%
2001 -57.20%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.40 -12.58%
AU
$140.81 475.44%
US
$765.25 7.74%
CH